Search Results - Craig N. Robson

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    A systematic review reveals conflicting evidence for the prevalence of antibodies against the sialic acid ‘xenoautoantigen’ Neu5Gc in humans and the need for a standardised approac... by Esme Hutton, Esme Hutton, Emma Scott, Craig N. Robson, Nathalie Signoret, Martin A. Fascione

    Published in Frontiers in Molecular Biosciences (2024-04-01)
    Get full text
    Article


  2. 2

    p68/DdX5 supports β-catenin & RNAP II during androgen receptor mediated transcription in prostate cancer. by Emma L Clark, Christiana Hadjimichael, Richard Temperley, Amy Barnard, Frances V Fuller-Pace, Craig N Robson

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


  3. 3

    Human α(2)β(1)(HI) CD133(+VE) epithelial prostate stem cells express low levels of active androgen receptor. by Stuart C Williamson, Anastasia C Hepburn, Laura Wilson, Kelly Coffey, Claudia A Ryan-Munden, Deepali Pal, Hing Y Leung, Craig N Robson, Rakesh Heer

    Published in PLoS ONE (2012-01-01)
    Get full text
    Article


  4. 4

    Side population in human non-muscle invasive bladder cancer enriches for cancer stem cells that are maintained by MAPK signalling. by Anastasia C Hepburn, Rajan Veeratterapillay, Stuart C Williamson, Amira El-Sherif, Neha Sahay, Huw D Thomas, Alejandra Mantilla, Robert S Pickard, Craig N Robson, Rakesh Heer

    Published in PLoS ONE (2012-01-01)
    Get full text
    Article


  5. 5

    Targeting the DNA double strand break repair machinery in prostate cancer. by Fadhel S Shaheen, Pawel Znojek, Ann Fisher, Martin Webster, Ruth Plummer, Luke Gaughan, Graeme C M Smith, Hing Y Leung, Nicola J Curtin, Craig N Robson

    Published in PLoS ONE (2011-01-01)
    Get full text
    Article


  6. 6

    Identification of novel androgen-regulated pathways and mRNA isoforms through genome-wide exon-specific profiling of the LNCaP transcriptome. by Prabhakar Rajan, Caroline Dalgliesh, Phillippa J Carling, Thomas Buist, Chaolin Zhang, Sushma N Grellscheid, Kelly Armstrong, Jacqueline Stockley, Cedric Simillion, Luke Gaughan, Gabriela Kalna, Michael Q Zhang, Craig N Robson, Hing Y Leung, David J Elliott

    Published in PLoS ONE (2011-01-01)
    Get full text
    Article


  7. 7

    Characterisation of a Tip60 specific inhibitor, NU9056, in prostate cancer. by Kelly Coffey, Timothy J Blackburn, Susan Cook, Bernard T Golding, Roger J Griffin, Ian R Hardcastle, Lorraine Hewitt, Kety Huberman, Hesta V McNeill, David R Newell, Celine Roche, Claudia A Ryan-Munden, Anna Watson, Craig N Robson

    Published in PLoS ONE (2012-01-01)
    Get full text
    Article


  8. 8

    The catalytic subunit of DNA-PK regulates transcription and splicing of AR in advanced prostate cancer by Beth Adamson, Nicholas Brittain, Laura Walker, Ruaridh Duncan, Sara Luzzi, Pasquale Rescigno, Graham Smith, Suzanne McGill, Richard J.S. Burchmore, Elaine Willmore, Ian Hickson, Craig N. Robson, Denisa Bogdan, Juan M. Jimenez-Vacas, Alec Paschalis, Jonathan Welti, Wei Yuan, Stuart R. McCracken, Rakesh Heer, Adam Sharp, Johann S. de Bono, Luke Gaughan

    Published in The Journal of Clinical Investigation (2023-11-01)
    Get full text
    Article


  9. 9

    ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer by Rebecca Garnham, Daniel Geh, Ryan Nelson, Erik Ramon-Gil, Laura Wilson, Edward N. Schmidt, Laura Walker, Beth Adamson, Adriana Buskin, Anastasia C. Hepburn, Kirsty Hodgson, Hannah Kendall, Fiona M. Frame, Norman Maitland, Kelly Coffey, Douglas W. Strand, Craig N. Robson, David J. Elliott, Rakesh Heer, Matthew Macauley, Jennifer Munkley, Luke Gaughan, Jack Leslie, Emma Scott

    Published in Communications Biology (2024-03-01)
    Get full text
    Article


Search Tools: